Prolonged efficacy of the 300IR 5‐grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prolonged efficacy of the 300IR 5‐grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score

Published:2015-01 Issue:1 Volume:5 Page:12
ISSN:2045-7022
Container-title:Clinical and Translational Allergy
language:en
Short-container-title:Clinical and Translational Allergy

Author:

Didier Alain¹,Malling Hans‐Jørgen²,Worm Margitta³,Horak Friedrich⁴,Sussman Gordon L⁵

Affiliation:

1. Rangueil‐Larrey HospitalDepartment of Respiratory Diseases24 Chemin de PouvourvilleTSA 30030 31059ToulouseCedex 9France

2. Allergy ClinicCopenhagen University HospitalGentofteDenmark

3. Department of Dermatology and AllergyCharité – Universitätsmedizin BerlinBerlinGermany

4. Vienna Challenge ChamberInstitute for Allergy ResearchViennaAustria

5. Division of Allergy and Clinical ImmunologyUniversity of TorontoTorontoONCanada

Publisher

Wiley

Subject

Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1186/s13601-015-0057-8

Reference23 articles.

1. The burden of allergic rhinitis and asthma;Ozdoganoglu T;Ther Adv Respir Dis,2012

2. Clinical efficacy of 300IR 5‐grass pollen sublingual tablet in a US study: the importance of allergen‐specific serum IgE;Cox LS;J Allergy Clin Immunol,2012

3. Optimal dose, efficacy, and safety of once‐daily sublingual immunotherapy with a 5‐grass pollen tablet for seasonal allergic rhinitis;Didier A;J Allergy Clin Immunol,2007

4. Efficacy and safety of 5‐grass‐pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis;Wahn U;J Allergy Clin Immunol,2009

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allergen Immunotherapy: The Evidence Supporting the Efficacy and Safety of Subcutaneous Immunotherapy and Sublingual Forms of Immunotherapy for Allergic Rhinitis/Conjunctivitis and Asthma;The Journal of Allergy and Clinical Immunology: In Practice;2024-06

2. The combination of allergen immunotherapy and biologics for inhalant allergies: Exploring the synergy;Annals of Allergy, Asthma & Immunology;2024-06

3. Allergen-specific immunotherapy for allergic asthma: What’s new?;Exploration of Asthma & Allergy;2024-02-29

4. The Korean Academy of Asthma Allergy and Clinical Immunology guidelines for sublingual immunotherapy;Allergy, Asthma & Respiratory Disease;2024

5. The KAAACI Guidelines for Sublingual Immunotherapy;Allergy, Asthma & Immunology Research;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3